AGEN Return on Tangible Equity | AGENUS INC

AGENUS INC (AGEN) Return on Tangible Equity

2026-06-30: Return Tang Equity -39.96%.
2026-03-31: Return Tang Equity -24.78%.
2025-12-31: Return Tang Equity 1.02%.
2025-09-30: Return Tang Equity 12.87%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-39.96%
2026-03-31	-24.78%
2025-12-31	1.02%
2025-09-30	12.87%
2025-06-30	44.19%
2025-03-31	52.35%
2024-12-31	65.00%
2024-09-30	72.25%
2024-06-30	84.76%
2024-03-31	107.28%
2023-12-31	134.12%
2023-09-30	176.11%
2023-06-30	220.43%
2023-03-31	275.60%
2022-12-31	246.32%
2022-09-30	437.68%
2022-06-30	-35.22%
2022-03-31	157.81%
2021-12-31	-1076.20%
2021-09-30	11.05%
2021-06-30	81.72%
2021-03-31	86.93%
2020-12-31	77.49%
2020-09-30	76.50%
2020-06-30	68.31%
2020-03-31	77.08%
2019-12-31	43.67%
2019-09-30	56.49%
2019-06-30	62.52%
2019-03-31	61.97%
2018-12-31	80.12%
2018-09-30	92.51%
2018-06-30	106.29%
2018-03-31	109.89%
2017-12-31	114.12%
2017-09-30	137.04%
2017-06-30	242.44%
2017-03-31	543.72%
2016-12-31	185.63%
2016-09-30	227.94%
2016-06-30	681.59%
2016-03-31	-706.22%
2015-12-31	-214.14%
2015-09-30	-189.16%
2015-06-30	-151.56%
2015-03-31	-287.46%
2014-12-31	2615.57%
2014-09-30	-73.34%
2014-06-30	-56.44%
2014-03-31	-56.35%
2013-12-31	426.39%
2013-09-30	545.69%
2013-06-30	141.90%
2013-03-31	94.74%
2012-12-31	56.14%
2012-09-30	75.69%
2012-06-30	84.05%
2012-03-31	79.86%
2011-12-31	99.46%
2011-09-30	105.52%
2011-06-30	100.61%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	1.02%
2024-12-31	65.02%
2023-12-31	134.20%
2022-12-31	246.64%
2021-12-31	-1029.42%
2020-12-31	77.53%
2019-12-31	43.69%
2018-12-31	80.15%
2017-12-31	114.25%
2016-12-31	185.96%
2015-12-31	-213.51%
2014-12-31	2615.57%
2013-12-31	426.39%
2012-12-31	56.14%
2011-12-31	99.46%
2010-12-31	126.78%
2009-12-31	178.60%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
C4 Therapeutics, Inc. (CCCC)	United States	$0.373B	-5.65
FENNEC PHARMACEUTICALS INC. (FENC)	United States	$0.371B	-115.85
Surrozen, Inc./DE (SRZN)	United States	$0.395B
Zura Bio Ltd (ZURA)		$0.398B	-6.56
Artiva Biotherapeutics, Inc. (ARTV)	United States	$0.367B
Cabaletta Bio, Inc. (CABA)	United States	$0.365B	-2.81
Scribe Therapeutics, Inc. (SCTX)	United States	$0.410B
Ocugen, Inc. (OCGN)	United States	$0.343B	-6.34
Editas Medicine, Inc. (EDIT)	United States	$0.424B	-4.29
Kyverna Therapeutics, Inc. (KYTX)	United States	$0.434B	-3.60